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Abstract: We used a combination of MD simulations and DFT calculations to reveal the precise chemical mechanism underlying the conversion 
of boronated nucleosides to natural nucleosides in the presence of hydrogen peroxide, which was recently experimentally demonstrated by 
Morihiro and Obika et al. (Chem. Sci. 2018, 9, 1112). Our results show that this process is initiated by the H2O2 deprotonation to a base concerted 
with the nucleophilic attack of the resulting OOH– anion onto the boron atom as the rate-limiting step of the overall transformation. This 
liberates a free base, followed by the 1,2-rearrangement to the C–OOH– adduct. Lastly, breaking of the O–O bond within the peroxide moiety 
cleaves the boron–carbon bond, giving boronic acid ester and the matching ketone as the final products. The obtained reaction profiles 
successfully interpret a much higher conversion rate of the thymine derivative over its guanine analogue, and rationalize why t-Bu-
hydroperoxide is hindering the conversion, thus placing both aspects in firm agreement with experiments. The offered insight represents a 
promising tool for the future synthetic approaches of stimuli-responsive biomolecules, especially chemically caged prodrug-type nucleic acid 
therapeutics, bearing significant importance due to their application potential in diagnostics and therapy of various genetic disorders. 
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INTRODUCTION 
TIMULI-responsive biomolecules have attracted grow-
ing attentions because of the possibility to control 
their functions and processes in biological environments, 
which opens the door for their potential application in the 
fields of chemical and synthetic biology. As a typical exam-
ple, photo-caged systems, which feature a photo-remova-
ble chemical group bound to a target biomolecule, have 
been explored for decades.[1] These are based on tempo-
rarily masking the activity of an investigated biomolecule, 
which can be restored by an external stimulus, such as 
photo-irradiation, to remove the introduced chemical 
groups (decaging). Moreover, recent progress and deeper 
understanding of bio-orthogonal chemical reactions have 
extended the scope of the stimuli towards other means of 
the bond cleavage reactions,[2] including Diels–Alder reac-
tion-triggered decaging to release active proteins,[3] a phos-
phine-mediated Staudinger reduction capable of activating 
proteins,[4] or a hydrogen peroxide (H2O2) mediated decag-
ing of proteins with phenylboronic acid derivatives.[5] 
Considering these seminal works on proteins and their pro-
gress, chemically caged nucleic acids are not yet sufficiently 
explored. 
 Deoxyribonucleic acid (DNA) is widely regarded as 
the cornerstone of biological heredity and a conveyor of 
genetic information.[6] The highly sensitive detection of dis-
tinct genetic sequences plays a pivotal role in gene therapy, 
medical diagnostics, food safety, biodefense applications, 
and environmental monitoring.[7] Highly sensitive DNA 
probes may thus be used as an effective tool for the early 
stage detection of genetic disorders, such as cancer,[8] 
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where both the sheer volume of the number of reported 
cases and the huge death toll indicate the importance of 
the development of efficient strategies for the early detec-
tion of these diseases to safeguard human health and 
further the advancement of allied research areas.[9]  
 With this in mind, it comes as a no surprise that sev-
eral antisense oligonucleotides (ASOs) have been under 
clinical development for the last few decades due to their 
promising therapeutic and diagnostic applications.[10] ASOs 
hybridize with complementary mRNA to regulate specific 
gene expression either via RNase H-induced strand scission, 
translational arrest caused by the steric blockade of the fac-
tors involved in translation, splicing and metabolism, or via 
splice switching.[10,11] Several antisense drugs have been 
approved by pharmaceutical regulatory agencies in recent 
years.[10,12] Although ASOs offer great potential to be a sim-
ple approach for the rational design of effective therapeu-
tics, their poor nuclease stability, binding affinity, 
physicochemical and pharmacokinetic properties are often 
cited as barriers to antisense drug development.[13] In order 
to improve in vivo pharmacokinetics, regulate the activity 
in a desirable manner and reduce the off-target effects of 
ASOs, using a desired stimuli-responsive moieties could be 
a valuable tool. 
 Small molecules can trigger the selective decaging to 
restore active biomolecules even in living cells.[2b,14] In 
addition, the chemical environment inside cells, which var-
ies depending on the physiological condition, can be 
employed to alter the properties of nucleic acids under a 
specific biomarker. It is known that while normal cells show 
very low reactive oxygen species (ROS) levels, cancer cells 
and inflamed cells exhibit increased levels of intracellular 
ROS including hydrogen peroxide, hydroxyl radical and 
superoxide anion.[15] H2O2 – a prominent ROS with a crucial 
role in carcinogenesis and cancer development[16] – is 
present in significant concentrations in vivo, and is thus an 
ideal candidate as a biomarker of tumors. The H2O2 levels 
in cancer cells are found to be in the range of 1 – 5 mM, 
significantly higher than those in normal cells (≈ 0.5 μM –  
1 mM).[17] These biological features of cancer and inflamed 
cells provide an opportunity for the selective prodrug 
design.[18]  
 In synthetic organic chemistry, H2O2 is a good 
uncharged nucleophile and can be used as a two-electron 
electrophilic oxidant.[18c] Moreover, it is well established 
that alkyl- or aryl boronic acids and their esters can be eas-
ily dissociated by H2O2 to the products which do not show 
any cytotoxicity, suggesting that the reaction between 
boronate moiety and H2O2 is chemospecific, bioorthogonal 
and biocompatible,[18] on top of the fact that many boron-
containing compounds are already in the clinical use.[19] 
Along these lines, Morihiro and Obika et al.[18b] very 
recently prepared a series of boronated nucleosides (Figure 
1A) and introduced O4-(4-boronobenzyl)-modified thymine 
into ASOs for the H2O2-triggered gene silencing in mamma-
lian cells. Namely, they masked the Watson-Crick face of 
the nucleobase with pinacol borane that sterically hindered 
duplex formation between the ASO and target mRNA. In 
the presence of H2O2, the boronate group was swiftly 
removed, resulting in gene silencing through hybridization 
of the ASO to the target mRNA. Although the authors pro-
posed that phenylboronic acid pinacol ester is first oxidized 
to phenol derivative by H2O2 and subsequent 1,6-elimina-
tion releases the active molecule (Figure 1B), the mecha-
nism of the activation is not fully clarified. In this work, we 
used a combination of molecular dynamics (MD) simula-
tions and density functional theory (DFT) calculations to 
provide deeper insights into the H2O2-triggered ASO activa-
tion and reveal that its precise chemical mechanism follows 
a different reaction sequence. Specifically, the reaction is 
initiated by the H2O2 deprotonation to a base concerted 
with the nucleophilic attack of the resulting HOO– onto the 
boron atom, being the rate-limiting process of the overall 
transformation. This liberates a free base, while the rest of 
the system undergoes an internal rearrangement from the 
boron-bound HOO– to a neighboring carbon-bound HOO– 
derivative. The following breaking of the O–O bond within 
the peroxide cleaves the carbon-boron bond, yielding 
boronic acid pinacol ester and the corresponding ketone as 
the final products. The obtained insight represents a prom-
ising tool for future synthetic approaches of prodrug-type 
nucleic acid therapeutics for selective disease treatment. 
 
 
Figure 1. (A) Structure of investigated boronated nucleosides 
based on thymine (1) and guanine (2), reactive oxygen species 
(3), and final products after the conversion (4–7).  
(B) Proposed mechanism for the H2O2-triggered conversion of 
boronated nucleosides to the corresponding natural 
nucleosides as suggested by Morihiro and Obika et al.[18b] 
 
 
 
 
  T. TANDARIĆ et al.: Hydrogen Peroxide-Responsive Antisense Nucleosides … 289 
 
DOI: 10.5562/cca3592 Croat. Chem. Acta 2019, 92(2), 287–295 
 
 
 
COMPUTATIONAL DETAILS 
Molecular Dynamics Simulations 
Molecular dynamics simulations were performed in order 
to sample the conformational space of the reacting 
complexes and elucidate representative structures for the 
subsequent density functional theory analysis. For all 
reactants, geometry optimization and RESP charge 
calculations were performed with the Gaussian 16 
program[23] at the HF/6–31G(d) level to be consistent with 
the employed GAFF force field. The formed reaction 
complexes were solvated in a truncated octahedral box of 
TIP3P water molecules spanning a 10 Å thick buffer and 
submitted to geometry optimization in AMBER16 
program,[24] employing periodic boundary conditions in all 
directions. Optimized systems were gradually heated from 
0 to 300 K and equilibrated during 30 ps using NVT 
conditions. This was followed by productive and 
unconstrained MD simulations of 300 ns employing a time 
step of 2 fs at a constant pressure (1 atm) and temperature 
(300 K), the latter held constant using Langevin thermostat 
with a collision frequency of 1 ps–1. The long-range 
electrostatic interactions were calculated employing the 
Particle Mesh Ewald method,[25] while the nonbonded 
interactions were truncated at 10.0 Å. Following MD 
simulations, the obtained structures were clustered 
according to the distance between the reactive oxygen 
atom on ROS and the boron atom on arylboronate-
modified nucleosides on every tenth structure from the last 
100 ns of simulations, and representative snapshots 
submitted to mechanistic DFT calculations. 
Density Functional Theory Calculations 
In order to minimize errors associated with the initial selec-
tion of starting geometries from MD trajectories, we tried 
several conformations of each reactive complex and pro-
ceeded with the mechanistic calculations using the most 
stable complexes. As a good compromise between accu-
racy and feasibility, all geometries were optimized in the 
gas-phase by the very efficient M06–2X/6–31+G(d) method 
with thermal Gibbs free energy corrections extracted from 
the corresponding frequency calculations without the scal-
ing factors. To account for the solvent effects, the final gas-
phase energies were corrected for the Gibbs solvation 
energies employing the SMD polarizable continuum model 
with all parameters corresponding to pure water, giving 
rise to (SMD)/M06–2X/6–31+G(d)//M06–2X/6–31+G(d) 
model employed here. The choice of this computational 
setup was prompted by its success in reproducing kinetic 
and thermodynamic parameters of various organic, organ-
ometallic and enzymatic reactions,[26] being particularly 
accurate for relative trends among similar reactants, which 
is the focus here. It is clear that such a methodology could 
be further improved by considering explicit solvation 
through any of the established QM/MM or EVB tech-
niques,[27] yet this is beyond the scope of current work, 
especially since experimental kinetic and thermodynamic 
parameters for the investigated processes are not known. 
All of the transition state structures were verified to have 
the appropriate imaginary frequency from which the corre-
sponding reactants and products were determined using 
the Intrinsic Reaction Coordinate (IRC) procedure.[28] 
Atomic charges were obtained by natural bond orbital 
(NBO) analyses[29] as the single-point calculations at the 
(SMD)/M06–2X/6–31+G(d) level. All of the calculations 
were performed using the Gaussian 16 software.[20] 
 
RESULTS AND DISCUSSION 
Structures of the investigated systems are depicted in 
Figure 1A and these involve boronated thymine (1) and 
guanine (2), as well as hydrogen peroxide (H2O2) and t-
butyl-hydroperoxide (TBHP) as reactive oxygen species. For 
the sake of simplicity, both nucleosides were truncated at 
the N-glycosidic position, where the sugar moiety was 
replaced by the N-methyl group. This is a reasonable 
approximation, since this position is very distant from the 
reactive boron-carbon bond in investigated nucleosides, 
and this modification should not have a significant impact 
on the obtained results. In this context, although our calcu-
lations were done on modified nitrogen bases, the 
obtained insight and conclusions are closely applicable to 
actual nucleosides as well, which is a terminology that we 
will keep throughout the text. The choice of these nucleo-
sides was prompted by the fact that Morihiro and Obika et 
al. demonstrated that, out of all four boronated systems, 
thymine derivative is most efficiently converted to the cor-
responding natural nucleoside, while guanine undergoes 
the least efficient conversion, both with H2O2.[18b] In addi-
tion, thymine is a pyrimidine, while guanine belongs to a 
purine class of nucleobases, which justifies their separate 
analysis. Lastly, both nucleosides were shown to be practi-
cally inactive towards TBHP, which deemed it worthwhile 
to investigate and rationalize such a dramatic influence of 
the t-Bu substituent effect on the reactivity. 
 Approach of H2O2 towards nucleosides generates 
reactive complexes in which one of the O–H groups forms 
a hydrogen bond with a base fragment, while the other is 
oriented in a way to stack above the aromatic phenyl ring 
(SP1, Figure 2). In 1, this hydrogen bond is established with 
the carbonyl oxygen on thymine, with the corresponding 
O∙∙∙O distance of 2.785 Å (SP1(1)). On the other hand, in 2, 
the latter is formed with the imino nitrogen in the five-
membered ring and the matching O∙∙∙N distance is slightly 
longer at 2.889 Å (SP1(2)). In both cases, this interaction  
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Figure 2. Geometries of selected stationary points (SP) and transition states (TS) for boronated thymine 1 and guanine 2. 
 
 
Figure 3. Reaction mechanism for the H2O2-triggered conversion of boronated nucleosides to natural nucleosides. The numbers 
indicate aqueous-phase Gibbs free-energies obtained by the (SMD)/M06–2X/6–31+G(d)//M06–2X/6–31+G(d) model (in  
kcal mol–1), and correspond to the depicted case for 1, while data in square brackets relate to the analogous situation in 2. 
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turns out to be crucial for the reactivity, as it enables the 
deprotonation of H2O2 to a base and the subsequent nucle-
ophilic reactivity of the formed perhydroxyl HOO– anion. 
The latter is accomplished onto the electrophilic site in 
nucleosides, which is a region around the B–C bond (Figure 
S1), which is exactly what needs to be cleaved to afford the 
final products.[18b] Without this deprotonation, the union-
ized H2O2 appears not to have enough nucleophilicity to 
perform the reaction, as all of our attempts to locate tran-
sition states (or even stable products) for its attack on the 
B atom or its neighboring aromatic C atom failed. Never-
theless, this is fully in line with the fact that, in organic 
chemistry, a typical H2O2-mediated oxidation is performed 
in the alkaline media,[20] where OH– performs the H2O2 
deprotonation (pKa = 11.54)[21] to give a nucleophilic HOO– 
anion. 
 With this in mind, we first investigated the approach 
of H2O2 towards the B atom in both 1 and 2 (Figure 3). In 
the transition structure TSSP1–SP2 there is a simultaneous 
formation of the new B–O bond accompanied with the per-
oxide deprotonation to a base (Figure 2). This reaction is 
feasible for both systems, yet the intrinsic barrier for 2 is by 
0.9 kcal mol–1 lower. This is easily explained knowing that 
guanine is a much stronger base than thymine,[22] therefore 
deprotonation to guanine is easier. However, guanine is a 
larger and more polar system, thus its solvation energy is 
higher, which makes it is less prone to oxidation. To firmly 
support that, our calculations for 1 and 2 gave the water-
solution solvation energies of –15.4 and –20.9 kcal mol–1, 
respectively. As a consequence, it is by 2.4 kcal mol–1 less 
favorable to form a reactive complex with 2 than it is with 
1, which increases the total activation free energy for 2 to 
33.2 kcal mol–1, being 1.5 kcal mol–1 higher than that for 1 
(Figure 3). This reaction gives a tetrahedral B–OOH– adduct 
SP2, and is slightly more favorable for guanine 2, although, 
for both nucleosides, the reaction is significantly ender-
gonic.  
 Following SP2, we investigated several mechanistic 
possibilities. A direct cleavage of the B–C bond, as proposed 
by Morihiro and Obika et al. to potentially give a phenol de-
rivative,[18b] does not offer good products. Namely, in this 
case, the mentioned C atom picks up hydrogen from the 
OOH group to form a phenyl moiety, which terminates the 
reaction. Analogously, the cleavage of the O–O bond within 
the peroxide and the formation of the OH adduct on the 
aromatic carbon atom is linked with a further barrier of 
28.8 kcal mol–1 for 1, which turns out to be one of the less 
feasible pathways, and later does not offer a viable route 
towards the final products. Interestingly, the formation of 
SP2 weakens the O–C bond connecting a base and a benzyl 
moiety, as evidenced in its elongation from 1.441 and  
1.438 Å in SP1 for 1 and 2, respectively, to 1.510 and 1.469 
Å in SP2, in the same order. This allows a very efficient 
release of a base, having a small barrier of 7.9 kcal mol–1 for 
1 and 17.3 kcal mol–1 for 2, to give a non-covalent complex 
between a base and the rest of the system (SP3), in which a 
base spontaneously tautomerizes to a more stable physio-
logical form, as in 4 and 5. It is worth noting that a significant 
difference in the height of these barriers in TSSP2–SP3 comes as 
a result of different extents of the O–C bond elongation, and 
is lower for a much longer O–C bond in SP2(1). A free base, 
then, leaves the complex, being favorable for both 1 (by  
5.2 kcal mol–1) and 2 (by 6.4 kcal mol–1), which allows it to 
undergo specific antisense pairing with the target DNA, 
thus forming basis for its potential therapeutic effect.  
 At this point on a reaction pathway, several observa-
tions are in place. Release of a free base leaves an interme-
diate SP4, which is high in energy (Figure 3), leading to a 
conclusion that it is not the end point of the whole process. 
Also, further steps, which should enable the thermody-
namic feasibility of the overall conversion, no longer 
depend on the initial substrate, as SP4 will be the same for 
all analogously boronated nucleosides. Yet, our calculations 
clearly show that the formation of SP4 is significantly more 
favorable for thymine 1 than it is for the guanidine ana-
logue 2. Namely, the overall barrier leading to SP4 is ΔG‡ = 
33.9 kcal mol–1 for 1, being 2.5 kcal mol–1 lower than for 2. 
Analogously, the reaction Gibbs free-energy until this point 
is ΔGR = 22.7 kcal mol–1 for 1, which is 5.3 kcal mol–1 more 
favorable than for 2 (Figure 3). Therefore, both kinetic and 
thermodynamic aspects strongly favor the transformation 
of 1 over 2. This is found in excellent agreement with 
experiments by Morihiro and Obika et al.,[18b] and nicely ex-
plains why thymine analogue 1 is much favorably converted 
to a free thymine 4 than 2 is to 5. The underlying reasons 
for that are several: (1) guanidine is larger and is better 
solvated in the solution, making it less prone to forming a 
reactive complex with H2O2 and undergoing the subse-
quent oxidation, and (2) its size allows the guanidine frag-
ment to more effectively distribute an excess positive 
charge formed upon its protonation in SP2, which leaves 
less positive charge around the bond connecting guanidine 
with the rest of the nucleoside, making its release less ef-
fective. The later is evidenced in the NBO charges at the 
corresponding oxygen atom in SP1 being –0.55 |e| for both 
1 and 2, respectively, which are changed to –0.58 and  
–0.60 |e| in SP2, in the same order.  
 SP4 intermediate features OOH– bound to the boron 
atom. From that, we considered several routes, but the 
only feasible pathway involved the cleavage of the B–OOH– 
bond and the 1,2-rearrangement to the C–OOH– adduct 
SP5. This is facilitated by the fact that the latter is by  
5.1 kcal mol–1 more stable, while the barrier to achieve it is 
moderate at 8.7 kcal mol–1. In the last step there is a 
cleavage of the O–O bond in the peroxide fragment 
accompanied by a simultaneous boron-carbon cleavage 
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and the B–O bond forming reaction (TSSP5–SP6, Figure 2). The 
barrier for this process is 23.5 kcal mol–1, and the reaction 
is highly exergonic to give SP6 involving a complex of 
boronic acid pinacol ester 6 and the matching ketone 7. 
Dissociation of both products is thermodynamically further 
favorable, giving the overall reaction free-energies of ΔGR = 
–91.1 kcal mol–1 for 1 and ΔGR = –85.8 kcal mol–1 for 2. It is 
worth noting that, on top of its demonstrated kinetic 
feasibility, the calculated thermodynamic aspects also 
support the conversion of 1 as more favorable, in line with 
experiment.[18b]  
 As an alternative, following the reactive complex 
SP1, the reaction could potentially proceed through the 
nucleophilic attack of H2O2 onto the aromatic carbon atom, 
since this site is also significantly electrophilic (Figure S1). 
This is an interesting pathway, since this process 
spontaneously liberates a base and immediately positions 
the resulting OOH– anion onto the aromatic carbon atom 
(SP2', Figure 4). Consequently, this sequence of events 
reduces the number of steps for the already demonstrated 
feasible pathway connecting SP1 to SP5 (Figure 3), which 
initially required three steps, into a single reaction. 
However the barrier for this process is very high, being ΔG‡ 
= 56.0 kcal mol–1 for 1 and ΔG‡ = 53.0 kcal mol–1 for 2, which 
is much higher than those calculated for the previous 
pathway. All of this renders the mechanism, which is 
initiated through the addition of H2O2 onto the aromatic 
carbon atom, as very implausible. 
 Unlike H2O2, which is a symmetrical molecule, its 
tert-butyl analogue TBHP is an unsymmetrical system, with 
the oxygen atom bearing the t-Bu group being considerably 
more nucleophilic than its O–H counterpart (Figure S1). 
Nevertheless, its initial reactive complex is identical to that 
of H2O2 in a way that a stable hydrogen bonding with a base 
is formed (SP1, Figure 2), with d(O∙∙∙O) = 2.761 Å in 1 and 
d(O∙∙∙N) = 2.798 Å in 2. However, although our attempts to 
model the analogous approach of the O(t-Bu) atom in TBHP 
on either boron or carbon atom in 1 and 2 gave stable prod-
ucts, such a reaction proceeds by cleaving the O–O bond in 
TBHP followed by the departure of the reactive hydroxyl 
anion OH–. The latter spontaneously binds to different po-
sitions on each nucleoside, thus preventing further conver-
sion, and not leading to final products. As an illustration, 
the attack of the O(t-Bu) atom on the aromatic carbon in 1 
is associated with a barrier of ΔG‡ = 89.4 kcal mol–1 and the 
produced OH– forms a chemical bond with the neighboring 
ortho-carbon on the phenyl ring, thus is clearly not feasible 
and unproductive. On the other hand, a scenario analogous 
to that depicted in Figure 3 would involve the attack of the 
less nucleophilic O(H) moiety on the boron atom. Still, dur-
ing this approach, TBHP rotates in a way to lose the hydro-
gen bonding with a base for the hydrogen bonding with one 
of the O-atom on the boronic ester (SP1'(2), Figure 2), thus 
giving the unproductive orientation. This is a stable struc-
ture, which is facilitated by the favorable C–H∙∙∙∙∙π 
interactions that t-Bu hydrogen atoms form with aromatic 
 
 
Figure 4. Alternative reaction pathway initiated through the nucleophilic attack of H2O2 onto the aromatic carbon atom in 
boronated nucleosides. The numbers indicate aqueous-phase Gibbs free-energies obtained by the (SMD)/M06–2X/6–
31+G(d)//M06–2X/6–31+G(d) model (in kcal mol–1), and correspond to the depicted case for 1, while data in square brackets 
relate to the analogous situation in 2. 
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moieties on both the phenyl group and a base. Still, in this 
orientation, the attack of the O(H) from TBHP onto the B-
atom is feasible and the barrier for that is reasonable at ΔG‡ 
= 34.4 kcal mol–1, with ΔGR = 13.2 kcal mol–1. Nevertheless, 
the product of that reaction is HOO– bound to the B-atom 
with a proton residing on the O(B) moiety. This prevents a 
favorable release of a base, and all other mechanistic 
options failed to give the right products. Alternatively, forc-
ing TBHP to approach the electrophilic B-atom in an orien-
tation that maintains the hydrogen bonding to a base, 
allows a mechanism analogous to that in Figure 3. How-
ever, the barrier for the transition SP1→SP2 with 1 is ΔG‡ = 
41.2 kcal mol–1, being 9.5 kcal mol–1 higher than in a reac-
tion with H2O2. This is found in excellent agreement with 
experiments,[18b] which revealed that the selectivity of 1 
towards H2O2 is around 16-times higher than towards 
TBHP. All of this lends strong credence to our results and 
supports the proposed mechanism. Moreover, this kinetic 
aspect is also combined with a better thermodynamic fea-
sibility of the whole transformation, which for H2O2 is  
ΔGR = –91.1 kcal mol–1 (Figure 3), while for TBHP it is ΔGR =  
–83.4 kcal mol–1.  
 Lastly, although Morihiro and Obika et al.,[18b] did not 
investigate the reactivity of TBHP with boronated guani-
dine 2, our calculations show that this process would be 
even less favorable than that for the mentioned reaction 
between H2O2 and 2. Specifically, the first transition state 
TSSP1–SP2 would be 44.0 kcal mol–1 above individual reac-
tants, 2.8 kcal mol–1 higher than with H2O2, while the reac-
tion Gibbs free-energy would be the least favorable of all 
examined here at ΔGR = –78.1 kcal mol–1. Along these lines, 
considering the mechanism presented in Figure 3, we can 
reasonably speculate that very low conversion rates of 1 with 
other reactive oxygen species examined experimentally,[18b] 
such as OCl•, HO•, tBuO•, O2• and NO, are likely attributed to 
(i) the non-existence of the acidic hydrogen in these systems, 
which would protonate the base and allows its effective 
release, and also to (ii) a well-demonstrated non-selective 
high reactivity of these open-shell systems,[15] which is 
certainly not limited to the most electrophilic regions around 
the B–C bond in 1–2. Any process other than that would give 
non-productive conversions of such and similar boronated 
nucleosides, and would disfavor the appropriate antisense 
pairing with target DNA molecules, thus is of no interest here.  
 
CONCLUSIONS 
In this work we used a combination of molecular dynamics 
simulations and density functional theory calculations to 
reveal the precise molecular mechanism governing the hy-
drogen peroxide-triggered conversion of boronated nucle-
osides into natural nucleosides, which was very recently 
experimentally demonstrated by Morihiro and Obika et 
al.[18b] By investigating several mechanistic possibilities, we 
showed that this process involves several steps and is initi-
ated by the nucleophilic attack of H2O2 onto the boron 
atom of the substrate, where the resulting B–O bond for-
mation is concerted with the hydrogen peroxide deproto-
nation to a base fragment. This is followed by the release 
of a free base, and the 1,2-rearrangement of the formed B–
OOH– adduct into the C–OOH– adduct. Lastly, the latter un-
dergoes the O–O bond cleavage within the peroxide moi-
ety, which gives boronic acid pinacol ester and the 
corresponding ketone as the final products. In this way our 
results contradict those by Morihiro and Obika et al.,[18b] 
which suggested that initial nucleosides are first oxidized to 
phenol derivatives and that a subsequent 1,6-elimination 
releases the active molecules. 
 The obtained kinetic and thermodynamic parame-
ters are consistent in confirming that the H2O2-mediated 
conversion of the thymine derivative 1 is more favorable 
than that of the guanine analogue 2, as its both activation 
and reaction free energies are by ΔΔG‡ = 2.5 kcal mol–1 and 
ΔΔGR = 5.3 kcal mol–1, respectively, more favorable than 
those calculated for 2. In this way, our results are found in 
excellent agreement with those reported experimen-
tally,[18b] which revealed the same trend among nucleo-
sides. In addition, we showed that the reaction with tBu-
derivative TBHP is hindered by the unproductive hydrogen 
bonding of its O–H moiety with the oxygen atom of the pi-
nacol fragment, which does not allow the protonation of 
the base moiety and its efficient release. Nevertheless, the 
overall conversion of 1 with TBHP is still possible, yet the 
calculated barrier is 9.5 kcal mol–1 higher than in the reac-
tion with H2O2. This also nicely ties in with Morihiro and 
Obika et al.,[18b] which revealed that the selectivity of 1 to-
wards H2O2 is around 16-times higher than towards TBHP. 
Taken all together, all of this lends credence to our results 
and strongly supports the proposed mechanism. 
 Given the growing attention and significant progress 
in the development, deeper understanding and wide-
spread application of stimuli-responsive proteins, we hope 
that presented results will aid in directing the attention of 
researchers towards reaching the same level of knowledge 
and sophistication with chemically caged nucleic acids. 
These may likely find their use in the early stage detection 
of genetic disorders, such as cancer, which is becoming of 
utmost importance and urgency from both the sheer vol-
ume of the number of reported cases of genetic disorders 
and the huge death toll. 
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